translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
News and Views

October 19, 1989
Nature (10/19/89) Vol. 341, No. 6243, P. 566

The lack of standard reagents, including viruses, makes comparing AIDS research from different laboratories problematic, especially in the case of vaccine research. In Europe, the European Communities have launched the EVA, or European vaccine against AIDS, which will use most of its 2.5 million ECU budget for production and distribution of reagents. The National Institute for Biological Standards and Control in South Mimms, United Kingdom, will monitor quality control, storage, and distribution of the reagents, which will be produced in several laboratories to agreed specifications.